longevity science
Stop Using Longevity Science Grants - Start Prioritizing Preclinical Outcomes
Stop Using Longevity Science Grants - Start Prioritizing Preclinical Outcomes We should stop using longevity science grants and start prioritizing preclinical outcomes, because the current grant model rarely translates into approved therapies. Only 2% of those grants lead to FDA-approved treatments, despite a $12 billion annual spend. Medical Disclaimer: This